![APASL 2023 Taiwan Congress Report APASL congress report thumbnail APASL congress report thumbnail](https://clinicalvalue.com/wp-content/uploads/2023/05/APASL-congress-report-thumbnail-1280x720.jpg)
31 May 2023
APASL 2023 Taiwan Congress Report
Catch up on the highlights of APASL 2023 with this congress report, covering session on hepatitis B, hepatitis C, hepatocellular carcinoma, and fatty liver disease.
READ MOREYou are about to leave the Clinical Value website now.
Catch up on the highlights of APASL 2023 with this congress report, covering session on hepatitis B, hepatitis C, hepatocellular carcinoma, and fatty liver disease.
READ MOREA panel of 17 experts from Asia-Pacific, gathered to discuss and reach a consensus on the clinical usefulness and value of PIVKA-II for the surveillance and…
READ MOREThese latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia-Pacific region, which has a diversity of medical environments.…
READ MORE